Fig. 1.
Fig. 1. Kinetics of plasma cell differentiation. / Resting memory cells were activated for 4 days with CD40L+fibroblasts in the presence of 50 U/mL IL-2 and 100 ng/mL IL-10 as described in “Materials and methods.” At the end of activation, cells were harvested and washed. Activated B cells (day 0) were then recultured for 7 days with IL-2 and IL-10 in the presence of anti-CD40L mAb. The cell phenotype was analyzed in double-staining with anti-CD38–PE mAb and anti-CD20–FITC mAb (A, B) or in triple-staining with anti-CD38–PE, anti-CD20–FITC, and anti-CD138–PECy5 mAbs (C-F). (A) Activated B cells CD20+CD38±; (B) preplasmablasts CD20±CD38+; (C, E) plasmablasts CD20−CD38++CD138−; and (D, F) early plasma cells CD20−CD38+++CD138++. Results are representative of 1 out of more than 10 experiments. Insert: Changes in viable cell number during PC generation. Apoptotic cells were identified and counted by Apo2.7 staining. Results are given as the mean ± SD of 6 experiments.

Kinetics of plasma cell differentiation.

Resting memory cells were activated for 4 days with CD40L+fibroblasts in the presence of 50 U/mL IL-2 and 100 ng/mL IL-10 as described in “Materials and methods.” At the end of activation, cells were harvested and washed. Activated B cells (day 0) were then recultured for 7 days with IL-2 and IL-10 in the presence of anti-CD40L mAb. The cell phenotype was analyzed in double-staining with anti-CD38–PE mAb and anti-CD20–FITC mAb (A, B) or in triple-staining with anti-CD38–PE, anti-CD20–FITC, and anti-CD138–PECy5 mAbs (C-F). (A) Activated B cells CD20+CD38±; (B) preplasmablasts CD20±CD38+; (C, E) plasmablasts CD20CD38++CD138; and (D, F) early plasma cells CD20CD38+++CD138++. Results are representative of 1 out of more than 10 experiments. Insert: Changes in viable cell number during PC generation. Apoptotic cells were identified and counted by Apo2.7 staining. Results are given as the mean ± SD of 6 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal